How this doc is embracing AI in oncology—and why you should, too

Clinical oncology, as Sanjay Juneja, MD, so aptly puts it, can feel like a never-ending chess match—against yourself.

Each diagnosis, treatment decision, and patient outcome adds another layer of complexity to the board, leaving oncologists wondering: Did I make the right move? Was there a better option I missed? And most persistently, could I have improved the outcome?

For oncologists, this mental tug-of-war doesn’t end when the patient leaves the office. The uncertainty lingers, influencing future decisions and challenging the effectiveness of care. And yet, this is the reality many cancer specialists face every day.

But what if the path forward could be less about second-guessing and more about learning from each experience? This is where artificial intelligence (AI) steps in.

This doc’s take on embracing AI

Dr. Juneja’s take on AI in oncology is both optimistic and pragmatic. He sees AI not as a replacement for human judgment, but as a powerful tool to augment the decision-making process.

His approach reflects a broader shift in the oncology community: embracing AI to help manage the complexities of cancer care, rather than viewing it as a threat or an unwelcome change.

Just as AI systems learn from thousands of chess games, oncology can benefit from the wealth of data generated by each case. By feeding AI systems with vast amounts of information—outcomes from various treatments, patient responses, genetic data, and clinical notes—we could see a significant improvement in decision-making.

As Dr. Juneja points out, the long history of AI learning from games like chess has proven its potential to navigate complex decision-making scenarios.

In oncology, the same concept applies: Can we leverage AI to sift through years of experience and clinical data, helping us make better, faster decisions for cancer patients?

Dr. Juneja continued: "The parallel to cancer care isn't hard to see. It's why I'm both optimistic about and committed to AI in oncology. We need every advantage we can get."

Plenty of fellow doctors—and even patients—agreed with Dr. Juneja's take.

"Couldn’t agree more. I think onc x AI is 🔥 excited for what’s to come," said oncologist Maria Borrero, MD, in a comment.

Additionally, journalist and speaker Loriana Hernández Aldama commented: "100%! Great analogy. As a 2x cancer survivor and advocate, this is such a key point to make."

A new way to strategize cancer care

AI’s role in oncology goes beyond just improving decision-making. It’s about developing a tool that helps oncologists anticipate the next best move.

With AI analyzing trends, predicting outcomes, and continuously refining its learning, the process of diagnosing and treating cancer could become more streamlined and, ultimately, more effective.

While there are still hurdles to overcome in fully integrating AI into clinical settings, Dr. Juneja’s enthusiasm signals the growing acceptance of AI as a valuable ally in oncology.

It’s about minimizing errors and finding new treatment options, yes, but it’s also about leveraging technology to guide oncologists in their decision-making, reducing uncertainty, and improving patient outcomes.

The future of AI in oncology

The chessboard of cancer care is vast and intricate. There are so many variables to consider—each patient is different, and their cancer may behave uniquely.

While oncologists have years of training and experience to guide them, there's always a level of uncertainty that can feel overwhelming. Sometimes, despite the best efforts, outcomes are less than ideal.

The optimistic view of AI in oncology is that it will not just reduce the uncertainty but actively guide oncologists in their decision-making, enabling them to make more informed, timely, and confident choices.

The goal is clear: Reduce the guesswork and enhance the precision of care to ultimately improve patient outcomes.